新发2型糖尿病心脏自主神经功能障碍与血浆脂质代谢物升高相关
该研究在新发1型(n=100)和2型糖尿病(n=206)患者中检测127种血浆脂质代谢物,并在3小时高胰岛素-正常血糖钳夹期间计算心率变异性指标。结果发现,在2型糖尿病中,特定磷脂酰胆碱和鞘磷脂水平较高与心率变异性降低独立相关,而1型糖尿病无此关联;5年后心率变异性下降主要与衰老而非糖尿病相关。
要点
- 新发2型糖尿病中,特定磷脂酰胆碱和鞘磷脂升高与心率变异性降低独立相关。
- 新发1型糖尿病中未观察到脂质代谢物与心脏自主神经功能的关联。
- 5年后心率变异性下降主要归因于衰老,而非糖尿病本身。
核心结论
- 新发2型糖尿病中,特定血浆脂质代谢物水平升高与心脏自主神经功能障碍密切相关,而1型糖尿病无此关联。
研究设计与样本
- 德国糖尿病研究基线队列,纳入新诊断1型糖尿病100例和2型糖尿病206例,用质谱分析127种血浆脂质代谢物,并在3小时高胰岛素-正常血糖钳夹期间计算心率变异性指标。
主要发现
- 2型糖尿病中,SDNN与PCaa C32:0、PCaa C34:1、PCae C36:0、SM C16:0和SM C16:1水平升高呈负相关。
- 相邻NN间期差值的标准差与PCaa C32:0、PCaa C34:1、PCaa C34:2、PCae C36:0和SM C16:1呈负相关;RMSSD与PCae C36:0呈负相关。
- VLF功率与PCaa C30:0、PCaa C32:0、PCaa C32:1、PCaa C34:2和SM C16:1呈负相关;LF功率与PCaa C32:0和SM C16:1呈负相关(r=-0.242至r=-0.349;所有相关性p≤0.0005)。
- 新发1型糖尿病中未观察到脂质代谢物与心脏自主神经功能指标的关联。
- 5年后心率变异性因衰老而非糖尿病下降,脂质代谢物的预测分析受限。
临床怎么用
- 对新发2型糖尿病患者,可关注特定磷脂酰胆碱和鞘磷脂水平,作为心脏自主神经功能障碍的潜在早期关联标志。
局限性
- 5年后脂质代谢物对心率变异性下降的预测分析因样本量受限而未能充分进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Emerging evidence suggests that in addition to hyperglycaemia, dyslipidaemia could represent a contributing pathogenetic factor to diabetic neuropathy, while obesity and insulin resistance play a role in the development of diabetic cardiac autonomic neuropathy (CAN) characterised by reduced heart rate variability (HRV), particularly in type 2 diabetes. We hypothesised that distinct lipid metabolites are associated with diminished HRV in recent-onset type 2 diabetes rather than type 1 diabetes. METHODS: We analysed 127 plasma lipid metabolites (11 acylcarnitines, 39 NEFA, 12 sphingomyelins (SMs), 56 phosphatidylcholines and nine lysophosphatidylcholines) using MS in participants from the German Diabetes Study baseline cohort recently diagnosed with type 1 (n = 100) and type 2 diabetes (n = 206). Four time-domain HRV indices (number of normal-to-normal (NN) intervals >50 ms divided by the number of all NN intervals [pNN50]; root mean square of successive differences [RMSSD]; SD of NN intervals [SDNN]; and SD of differences between adjacent NN intervals) and three frequency-domain HRV indices (very-low-frequency [VLF], low-frequency [LF] and high-frequency [HF] power spectrum) were computed from NN intervals recorded during a 3 h hyperinsulinaemic-euglycaemic clamp at baseline and in subsets of participants with type 1 (n = 60) and type 2 diabetes (n = 95) after 5 years. RESULTS: In participants with type 2 diabetes, after Bonferroni correction and rigorous adjustment, SDNN was inversely associated with higher levels of diacyl-phosphatidylcholine (PCaa) C32:0, PCaa C34:1, acyl-alkyl-phosphatidylcholine (PCae) C36:0, SM C16:0 and SM C16:1. SD of differences between NN intervals was inversely associated with PCaa C32:0, PCaa C34:1, PCaa C34:2, PCae C36:0 and SM C16:1, and RMSSD with PCae C36:0. For VLF power, inverse associations were found with PCaa C30:0, PCaa C32:0, PCaa C32:1, PCaa C34:2 and SM C16:1, and for LF power inverse associations were found with PCaa C32:0 and SM C16:1 (r = -0.242 to r = -0.349; p ≤ 0.0005 for all correlations). In contrast, no associations of lipid metabolites with measures of cardiac autonomic function were noted in participants recently diagnosed with type 1 diabetes. After 5 years, HRV declined due to ageing rather than diabetes, whereby prediction analyses for lipid metabolites were hampered. CONCLUSIONS/INTERPRETATION: Higher plasma levels of specific lipid metabolites are closely linked to cardiac autonomic dysfunction in recent-onset type 2 diabetes but not type 1 diabetes, suggesting a role for perturbed lipid metabolism in the early development of CAN in type 2 diabetes. Graphical abstract.
引用
- Ziegler D, Strom A, Straßburger K, et al. Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes. Diabetologia. 2020. PMID: 33084971. doi:10.1007/s00125-020-05310-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。